ResearchSpace

Scoping review on lead user engagement methods in the development of telemedicine products

Show simple item record

dc.contributor.author Bhebhe, M
dc.contributor.author Grobbelaar, S
dc.contributor.author Herselman, Martha E
dc.date.accessioned 2024-01-11T09:09:13Z
dc.date.available 2024-01-11T09:09:13Z
dc.date.issued 2023-08
dc.identifier.citation Bhebhe, M., Grobbelaar, S. & Herselman, M.E. 2023. Scoping review on lead user engagement methods in the development of telemedicine products. http://hdl.handle.net/10204/13501 . en_ZA
dc.identifier.isbn 979-8-4007-0820-6
dc.identifier.uri https://doi.org/10.1145/3625156.3625195
dc.identifier.uri http://hdl.handle.net/10204/13501
dc.description.abstract There has been a major increase in the development of new telemedicine products post the Covid-19 pandemic. The need for these products continues to rise due to the expansion of the ageing population and the desire to have robust health systems that can cater to large populations. However, the success of these telemedicine products largely depends on their acceptance by users. The acceptance rate of products is arguably directly proportional to meeting user needs, ease of use and user comfortability to adopt the product. The latter is affected mainly by a large population expecting a walk-in service for medical attention, hence sidelining telemedicine products. A larger part of the world population does not yet trust the effectiveness of telemedicine products. To improve the adoption of these products, users need to be involved in their development. This increases the ability of products to meet end-user needs, hence their adoption. In this paper, we focus on how we can involve lead users in healthcare in developing telemedicine products. We termed these as "engagement methods". The aim is to highlight different engagement methods that can be used in different telemedicine product development scenarios. The results of this study help developers in the selection of an effective engagement method per development stage. Selecting the proper engagement method enables developers to utilise the lead user expertise in telemedicine product development fully. We also used content coding to identify the research gaps in the literature and postulate possible avenues for future engagement methods in new product development (NPD) in telemedicine. The research followed a structured literature review through the PRISMA protocol. The search strategy included analysing published articles from prior health research. Articles were retrieved from three (3) databases: Scopus, Web of Science and PubMed. Titles, abstracts and full texts of retrieved articles were screened for relevance and duplication. Inclusion was limited to health research articles that report on lead user involvement at least at one stage in new product development. The study provides scholars and practitioners with original and valuable contributions to the present literature on engagement methods in telemedicine product development. en_US
dc.format Abstract en_US
dc.language.iso en en_US
dc.relation.uri https://dl.acm.org/doi/10.1145/3625156.3625195 en_US
dc.source ICISS '23: Proceedings of the 6th International Conference on Information Science and Systems, Edinburgh, UK, 11-13 August 2023 en_US
dc.subject Engagement methods en_US
dc.subject Lead user en_US
dc.subject New product development en_US
dc.subject NPD en_US
dc.subject Telemedicine en_US
dc.title Scoping review on lead user engagement methods in the development of telemedicine products en_US
dc.type Conference Presentation en_US
dc.description.pages 273-280 en_US
dc.description.note © 2023 Copyright held by the owner/author(s). Publication rights licensed to ACM. Due to copyright restrictions, the attached PDF file only contains the abstract of the full text item. For access to the full text item, please consult the publisher's website: https://dl.acm.org/doi/10.1145/3625156.3625195 en_US
dc.description.cluster Next Generation Enterprises & Institutions en_US
dc.description.impactarea Technology Implementation ME en_US
dc.identifier.apacitation Bhebhe, M., Grobbelaar, S., & Herselman, M. E. (2023). Scoping review on lead user engagement methods in the development of telemedicine products. http://hdl.handle.net/10204/13501 en_ZA
dc.identifier.chicagocitation Bhebhe, M, S Grobbelaar, and Martha E Herselman. "Scoping review on lead user engagement methods in the development of telemedicine products." <i>ICISS '23: Proceedings of the 6th International Conference on Information Science and Systems, Edinburgh, UK, 11-13 August 2023</i> (2023): http://hdl.handle.net/10204/13501 en_ZA
dc.identifier.vancouvercitation Bhebhe M, Grobbelaar S, Herselman ME, Scoping review on lead user engagement methods in the development of telemedicine products; 2023. http://hdl.handle.net/10204/13501 . en_ZA
dc.identifier.ris TY - Conference Presentation AU - Bhebhe, M AU - Grobbelaar, S AU - Herselman, Martha E AB - There has been a major increase in the development of new telemedicine products post the Covid-19 pandemic. The need for these products continues to rise due to the expansion of the ageing population and the desire to have robust health systems that can cater to large populations. However, the success of these telemedicine products largely depends on their acceptance by users. The acceptance rate of products is arguably directly proportional to meeting user needs, ease of use and user comfortability to adopt the product. The latter is affected mainly by a large population expecting a walk-in service for medical attention, hence sidelining telemedicine products. A larger part of the world population does not yet trust the effectiveness of telemedicine products. To improve the adoption of these products, users need to be involved in their development. This increases the ability of products to meet end-user needs, hence their adoption. In this paper, we focus on how we can involve lead users in healthcare in developing telemedicine products. We termed these as "engagement methods". The aim is to highlight different engagement methods that can be used in different telemedicine product development scenarios. The results of this study help developers in the selection of an effective engagement method per development stage. Selecting the proper engagement method enables developers to utilise the lead user expertise in telemedicine product development fully. We also used content coding to identify the research gaps in the literature and postulate possible avenues for future engagement methods in new product development (NPD) in telemedicine. The research followed a structured literature review through the PRISMA protocol. The search strategy included analysing published articles from prior health research. Articles were retrieved from three (3) databases: Scopus, Web of Science and PubMed. Titles, abstracts and full texts of retrieved articles were screened for relevance and duplication. Inclusion was limited to health research articles that report on lead user involvement at least at one stage in new product development. The study provides scholars and practitioners with original and valuable contributions to the present literature on engagement methods in telemedicine product development. DA - 2023-08 DB - ResearchSpace DP - CSIR J1 - ICISS '23: Proceedings of the 6th International Conference on Information Science and Systems, Edinburgh, UK, 11-13 August 2023 KW - Engagement methods KW - Lead user KW - New product development KW - NPD KW - Telemedicine LK - https://researchspace.csir.co.za PY - 2023 SM - 979-8-4007-0820-6 T1 - Scoping review on lead user engagement methods in the development of telemedicine products TI - Scoping review on lead user engagement methods in the development of telemedicine products UR - http://hdl.handle.net/10204/13501 ER - en_ZA
dc.identifier.worklist 27390 en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record